Global Synthetic Biology Market
Global Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Analysis
02 juin 2022 06h58 HE | Research and Markets
Dublin, June 02, 2022 (GLOBE NEWSWIRE) -- The "Global Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Products, Technology, and Application" report has been added...
22157.jpg
Global Pharmaceuticals & Biotechnology Royalty Rates Report 2022 with Detailed Financial Information from Real-World Transactions
24 mai 2022 04h38 HE | Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Royalty Rates for...
factMR-logo.png
Growing Advancements in Life Science Research to Expand Oligonucleotide Synthesis Market: Fact.MR Study
15 mai 2022 19h00 HE | FACT.MR
United States, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) -- As per a recent report published by Fact.MR, the global oligonucleotide synthesis market is poised to grow at a CAGR of 11.3% from 2022...
Global Nucleic Acid Based Gene Therapy Market
Global $14.9 Bn Nucleic Acid Based Gene Therapy Markets, 2015-2020, 2025F, 2030F
07 avr. 2022 04h58 HE | Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030, By Nucleic Acid Technology, Application, End User" report has been...
22157.jpg
Worldwide Aptamers Industry to 2026 - Featuring Aptamer, Aptus Biotech and SomaLogic Among Others
01 déc. 2021 09h23 HE | Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...
22157.jpg
Worldwide Pharmaceutical Intermediates Industry to 2028 - Rising Prevalence of Chronic and Infectious Diseases is Driving Growth
30 août 2021 04h08 HE | Research and Markets
Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type; Applications; Distribution Channel, and Geography"...
QMI-Logo-Long-1000px.jpg
Global Oligonucleotide Synthesis Market Size to Grow at a CAGR of 17.6% from 2021 to 2030
16 juin 2021 06h30 HE | Quince Market Insights
Pune, India, June 16, 2021 (GLOBE NEWSWIRE) -- The global oligonucleotide synthesis market has been estimated to reach USD 6.5 billion in 2021 and is projected to grow at a CAGR of 17.6% during the...
logo.gif
Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning
03 juin 2021 07h30 HE | Auris Medical AG
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to enable extrahepatic delivery of...
mirecule logo.png
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
27 mai 2021 11h07 HE | miRecule
GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced today it has...
NapaJen Logo.jpg
NapaJen Pharma Reports Positive Results from Phase 1 Clinical Trial of Novel RNA Interference (RNAi) Therapeutic
08 oct. 2020 07h35 HE | NapaJen
NJA-730 is an Anti-CD-40 Oligonucleotide Combined with Beta-Glucan Delivery Vehicle with Potential to Treat Acute Graft-versus-Host Disease (aGvHD) Treatment Shown to be Safe and Well-Tolerated...